Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.
Source: MedTech Dive
You may also like
My Search for a Psychiatric Bed in an Overburdened...
Stereotaxis closes Robocath takeover
Resmed to sell MatrixCare for $490M to private equity...
CVS CEO says Aetna has a handle on medical costs in...
Whistleblower lawsuit accuses Alignment of accounting...
Physicians’ wearable data use hampered by...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.